EFDID: 305861EFD: View Filing

Issuer: GENEOS Therapeutics, Inc. (0001769177) - D

Accession: 0001769177-19-000001 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001769177
  • Entity Name:
    GENEOS Therapeutics, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Within 5 years (2016)
  • Address:
    660 WEST GERMANTOWN PIKE
    SUITE 110
    PLYMOUTH MEETING, PA 19462
  • Persons:
    Related Persons 5
    Niranjan Y. Sardesai
    Executive Officer, Director
    James Eadie
    Director
    Casey Cunningham
    Director
    Samuel Dr. Broder
    Director
    J. Joseph Kim
    Director
EDGAR: Offering Information
  • Accession Date:
    02/27/2019
  • First Sale Date:
    02/21/2019
  • Offering Amount:
    $10,499,993
  • Amount Sold:
    $4,499,998
  • Amount Remaining:
    $5,999,995
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity, Warrants to purchase Common Stock will be issued to M.M. Dillon & Co. and designees of Brookline Capital Markets in addition to any fees paid for commissions and financial advice.
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
William B. Buchanan, Jr. 1048722 CIM Securities, LLC (Brookline Capital Markets) 120852 CT, NY
Andrew D. Daniels 2251612 CIM Securities, LLC (Brookline Capital Markets) 120852 CT, NY
Angela C. Dong 4367592 CIM Securities, LLC (Brookline Capital Markets) 120852 CT, NY
John Dexter Pearson 6093501 CIM Securities, LLC (Brookline Capital Markets) 120852 CT, NY
Scott A. Katzmann 1087840 CIM Securities, LLC (Brookline Capital Markets) 120852 CT, NY
Harris R.L. Lydon Jr. 1796845 CIM Securities, LLC (Brookline Capital Markets) 120852 CT, NY
Graham A Powis 2420999 CIM Securities, LLC (Brookline Capital Markets) 120852 CT, NY
Samuel P. Wertheimer 5984076 CIM Securities, LLC (Brookline Capital Markets) 120852 CT, NY
M.M.Dillon & Co., LLC 19878 M.M. Dillon & Co., LLC 19878 CT, NY
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
GENEOS Therapeutics, Inc./w/Niranjan Y. SardesaiNiranjan Y. SardesaiPresident and Chief Executive Officer2019-02-27